300 related articles for article (PubMed ID: 35003106)
1. Anti-Interferon Autoantibodies in Adult-Onset Immunodeficiency Syndrome and Severe COVID-19 Infection.
Chen LF; Yang CD; Cheng XB
Front Immunol; 2021; 12():788368. PubMed ID: 35003106
[TBL] [Abstract][Full Text] [Related]
2. Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1.
Meisel C; Akbil B; Meyer T; Lankes E; Corman VM; Staudacher O; Unterwalder N; Kölsch U; Drosten C; Mall MA; Kallinich T; Schnabel D; Goffinet C; von Bernuth H
J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34061776
[TBL] [Abstract][Full Text] [Related]
3. Anti-interferon-γ autoantibody-associated immunodeficiency.
Shih HP; Ding JY; Yeh CF; Chi CY; Ku CL
Curr Opin Immunol; 2021 Oct; 72():206-214. PubMed ID: 34175547
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing Activity of Anti-interferon-γ Autoantibodies in Adult-Onset Immunodeficiency Is Associated With Their Binding Domains.
Yasamut U; Thongkum W; Moonmuang S; Sakkhachornphop S; Chaiwarith R; Praparattanapan J; Wipasa J; Chawansuntati K; Supparatpinyo K; Lai E; Tayapiwatana C
Front Immunol; 2019; 10():1905. PubMed ID: 31474987
[TBL] [Abstract][Full Text] [Related]
5. Minireview: Insights into anti-interferon-γ autoantibodies.
Chawansuntati K; Rattanathammethee K; Wipasa J
Exp Biol Med (Maywood); 2021 Apr; 246(7):790-795. PubMed ID: 33430618
[TBL] [Abstract][Full Text] [Related]
6. Editorial: Autoantibodies to Components of the Immune System, Including Type 1 Interferons, and the Risk of Severe COVID-19.
Parums DV
Med Sci Monit; 2021 Sep; 27():e934766. PubMed ID: 34538868
[TBL] [Abstract][Full Text] [Related]
7. Paradox of autoantibodies and immune deficiency: Interferon gamma antibodies and susceptibility to intracellular pathogens.
Sehgal S; Suri D
Indian J Med Microbiol; 2015; 33(4):473-6. PubMed ID: 26470950
[No Abstract] [Full Text] [Related]
8. Recurrent disseminated
Zeitler K; Walter J; Khan F; Sriaroon C
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33509870
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain.
Troya J; Bastard P; Planas-Serra L; Ryan P; Ruiz M; de Carranza M; Torres J; Martínez A; Abel L; Casanova JL; Pujol A
J Clin Immunol; 2021 Jul; 41(5):914-922. PubMed ID: 33851338
[TBL] [Abstract][Full Text] [Related]
10. Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia.
de Prost N; Bastard P; Arrestier R; Fourati S; Mahévas M; Burrel S; Dorgham K; Gorochov G; Tandjaoui-Lambiotte Y; Azzaoui I; Fernandes I; Combes A; Casanova JL; Mekontso-Dessap A; Luyt CE
J Clin Immunol; 2021 Apr; 41(3):536-544. PubMed ID: 33616813
[TBL] [Abstract][Full Text] [Related]
11. Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1.
Bastard P; Orlova E; Sozaeva L; Lévy R; James A; Schmitt MM; Ochoa S; Kareva M; Rodina Y; Gervais A; Le Voyer T; Rosain J; Philippot Q; Neehus AL; Shaw E; Migaud M; Bizien L; Ekwall O; Berg S; Beccuti G; Ghizzoni L; Thiriez G; Pavot A; Goujard C; Frémond ML; Carter E; Rothenbuhler A; Linglart A; Mignot B; Comte A; Cheikh N; Hermine O; Breivik L; Husebye ES; Humbert S; Rohrlich P; Coaquette A; Vuoto F; Faure K; Mahlaoui N; Kotnik P; Battelino T; Trebušak Podkrajšek K; Kisand K; Ferré EMN; DiMaggio T; Rosen LB; Burbelo PD; McIntyre M; Kann NY; Shcherbina A; Pavlova M; Kolodkina A; Holland SM; Zhang SY; Crow YJ; Notarangelo LD; Su HC; Abel L; Anderson MS; Jouanguy E; Neven B; Puel A; Casanova JL; Lionakis MS
J Exp Med; 2021 Jul; 218(7):. PubMed ID: 33890986
[TBL] [Abstract][Full Text] [Related]
12. The detectable anti-interferon-γ autoantibodies in COVID-19 patients may be associated with disease severity.
Chen PK; Yeo KJ; Chang SH; Liao TL; Chou CH; Lan JL; Chang CK; Chen DY
Virol J; 2023 Feb; 20(1):33. PubMed ID: 36810114
[TBL] [Abstract][Full Text] [Related]
13. Juvenile-Onset Immunodeficiency Secondary to Anti-Interferon-Gamma Autoantibodies.
Liew WK; Thoon KC; Chong CY; Tan NWH; Cheng DT; Chan BSW; Ng MSY; Das L; Arkachaisri T; Huang CH; Kuan JL; Chai LYA; Koh MJA
J Clin Immunol; 2019 Jul; 39(5):512-518. PubMed ID: 31177358
[TBL] [Abstract][Full Text] [Related]
14. Non-tuberculous mycobacterial infection and reactive dermatosis associated with adult-onset immunodeficiency due to anti-interferon-gamma autoantibodies: A case report.
Liang XN; Bin YF; Lai GT; Li YH; Zhang JQ; Zhong XN; Bai J; Li MH; Deng JM; He ZY
Medicine (Baltimore); 2020 Sep; 99(36):e21738. PubMed ID: 32899003
[TBL] [Abstract][Full Text] [Related]
15. Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs.
Lopez J; Mommert M; Mouton W; Pizzorno A; Brengel-Pesce K; Mezidi M; Villard M; Lina B; Richard JC; Fassier JB; Cheynet V; Padey B; Duliere V; Julien T; Paul S; Bastard P; Belot A; Bal A; Casanova JL; Rosa-Calatrava M; Morfin F; Walzer T; Trouillet-Assant S
J Exp Med; 2021 Oct; 218(10):. PubMed ID: 34357402
[TBL] [Abstract][Full Text] [Related]
16. Fatal Mycobacterium colombiense/cytomegalovirus coinfection associated with acquired immunodeficiency due to autoantibodies against interferon gamma: a case report.
Poulin S; Corbeil C; Nguyen M; St-Denis A; Côté L; Le Deist F; Carignan A
BMC Infect Dis; 2013 Jan; 13():24. PubMed ID: 23336346
[TBL] [Abstract][Full Text] [Related]
17. NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2-related complications.
Bodansky A; Vazquez SE; Chou J; Novak T; Al-Musa A; Young C; Newhams M; Kucukak S; Zambrano LD; Mitchell A; Wang CY; Moffitt K; Halasa NB; Loftis LL; Schwartz SP; Walker TC; Mack EH; Fitzgerald JC; Gertz SJ; Rowan CM; Irby K; Sanders RC; Kong M; Schuster JE; Staat MA; Zinter MS; Cvijanovich NZ; Tarquinio KM; Coates BM; Flori HR; Dahmer MK; Crandall H; Cullimore ML; Levy ER; Chatani B; Nofziger R; ; Geha RS; DeRisi J; Campbell AP; Anderson M; Randolph AG
J Allergy Clin Immunol; 2023 Apr; 151(4):926-930.e2. PubMed ID: 36509151
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous disseminated infections with intracellular pathogens: an intriguing case report of adult-onset immunodeficiency with anti-interferon-gamma autoantibodies.
Roerden M; Döffinger R; Barcenas-Morales G; Forchhammer S; Döbele S; Berg CP
BMC Infect Dis; 2020 Nov; 20(1):828. PubMed ID: 33176707
[TBL] [Abstract][Full Text] [Related]
19. Immune Alterations in Patients with Anti-Interferon-γ Autoantibodies.
Chruewkamlow N; Mahasongkram K; Pata S; Chaiwarith R; Salee P; Supparatpinyo K; Kasinrerk W
PLoS One; 2016; 11(1):e0145983. PubMed ID: 26727515
[TBL] [Abstract][Full Text] [Related]
20. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
